BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3109993)

  • 1. Effect of workup strategy on the cost-effectiveness of fecal occult blood screening for colorectal cancer.
    Barry MJ; Mulley AG; Richter JM
    Gastroenterology; 1987 Aug; 93(2):301-10. PubMed ID: 3109993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of screening for colorectal cancer in Japan.
    Tsuji I; Fukao A; Shoji T; Kuwajima I; Sugawara N; Hisamichi S
    Tohoku J Exp Med; 1991 Aug; 164(4):269-78. PubMed ID: 1746016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The workup of the asymptomatic patient with a positive fecal occult blood test.
    Brandeau ML; Eddy DM
    Med Decis Making; 1987; 7(1):32-46. PubMed ID: 3100902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.
    Vijan S; Hwang EW; Hofer TP; Hayward RA
    Am J Med; 2001 Dec; 111(8):593-601. PubMed ID: 11755501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of costs and effects of screening for colorectal cancer in the United States.
    Byers T; Gorsky R
    Cancer; 1992 Sep; 70(5 Suppl):1288-95. PubMed ID: 1387342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for colorectal cancer: the cost to find an advanced adenoma.
    McGrath JS; Ponich TP; Gregor JC
    Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of colon cancer screening.
    Lieberman D
    Am J Gastroenterol; 1991 Dec; 86(12):1789-94. PubMed ID: 1962624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness model for colon cancer screening.
    Lieberman DA
    Gastroenterology; 1995 Dec; 109(6):1781-90. PubMed ID: 7498642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening flexible sigmoidoscopy by primary care physicians. Effectiveness and costs in patients negative for fecal occult blood.
    Rumans MC; Benner KG; Keeffe EB; Custis JM; Lockwood DR; Craner GE
    West J Med; 1986 Jun; 144(6):756-8. PubMed ID: 3088841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How good is screening for colorectal cancer?
    Nostrant TT; Wilson JA
    Postgrad Med; 1983 Jun; 73(6):131-9. PubMed ID: 6856522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.
    O'Leary BA; Olynyk JK; Neville AM; Platell CF
    J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of rectal bleeding in adults. A cost-effectiveness analysis comparing four diagnostic strategies.
    Allen E; Nicolaidis C; Helfand M
    J Gen Intern Med; 2005 Jan; 20(1):81-90. PubMed ID: 15693933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexible sigmoidoscopy plus air-contrast barium enema versus colonoscopy for evaluation of symptomatic patients without evidence of bleeding.
    Rex DK; Mark D; Clarke B; Lappas JC; Lehman GA
    Gastrointest Endosc; 1995 Aug; 42(2):132-8. PubMed ID: 7590048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening: new opportunities.
    Levin TR
    Surg Oncol Clin N Am; 1999 Oct; 8(4):673-91, vi-vii. PubMed ID: 10452934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial evaluation of rectal bleeding in young persons: a cost-effectiveness analysis.
    Lewis JD; Brown A; Localio AR; Schwartz JS
    Ann Intern Med; 2002 Jan; 136(2):99-110. PubMed ID: 11790061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost benefit of early diagnosis of colorectal cancer.
    Bolin TD
    Scand J Gastroenterol Suppl; 1996; 220():142-6. PubMed ID: 8898453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of colorectal cancer screening.
    McMahon PM; Bosch JL; Gleason S; Halpern EF; Lester JS; Gazelle GS
    Radiology; 2001 Apr; 219(1):44-50. PubMed ID: 11274533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.